Abstract Coronavirus disease 2019 (COVID-19) represents an unmet clinical need, due to a
high mortality rate, rapid mutation rate in the virus, increased chances of reinfection, lack of …

Since the outbreak of the COVID-19 pandemic, the use of antiviral and other available drugs
has been considered to combat or reduce the clinical symptoms of patients. In this regard, it …

Favipiravir, a promising antiviral agent, is undergoing clinical trials for the potential treatment
of the novel coronavirus disease 2019 (COVID-19). This is the first report for the …

SARS-CoV-2 has caused a global pandemic of COVID-19 since its emergence in December
2019. The infection causes a severe acute respiratory syndrome and may also spread to …

Background We examined the safety and efficacy of a treatment protocol containing
Favipiravir for the treatment of SARS-CoV-2. Methods We did a multicenter randomized …

Abstract Until January 2023, Brazil recorded 37 million COVID-19 cases despite the
decrease in mortality due to mass vaccination efforts against COVID-19. The infection …

Objective The recent unprecedented pandemic caused by Sars-Cov-2 (the new coronavirus
2019), is threatening public health around the world. Although several studies have been …

This study developed a nanosensor for the detection and determination of favipiravir, a
presumed drug that has potential therapeutic efficacy in treating COVID‐19 patients, from …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread and led to global health crises …

COVID-19 crisis affects ovarium cancer patients seriously. Thus, it is vital to diagnose
ovarium cancer, one of the most common types of cancer diagnosed and the causes of …